BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
I am bullish on the niche industry that uses magnetic stimulation for brain therapies. BrainsWay and Neuronetics are US-listed stocks in this niche, however they are highly unprofitable with volatile ...
BrainsWay shows strong growth in TMS and new indications, but high costs, psychedelic competition & stretched valuation raise ...
Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments BURLINGTON, Mass. and JERUSALEM, April 15, 2026 (GLOBE ...
InvestorsHub on MSN
Brainsway Shares Jump After FDA Extends Deep TMS Approval to Teen Depression
Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, clearing the ...
BrainsWay Ltd. (NASDAQ:BWAY) stock is trading higher on Monday after the company announced a $20 million investment from Valor Equity Partners. The Details: BrainsWay will issue a total of 2,103,745 ...
Shortcuts aren’t common in medicine, but BrainsWay may have found an effective one for treating major depressive disorder. The company’s Deep Transcranial Magnetic Stimulation (Deep TMS) technology ...
Investors might want to bet on Brainsway Ltd. Sponsored ADR (BWAY), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term ...
CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments ...
Actively seeking to ramp up this strategic initiative with additional minority equity investments in high-performing mental health providers; partnered with Valor Equity Partners to identify ...
BrainsWay Ltd. (NASDAQ:BWAY) Q3 2025 Earnings Call Transcript November 11, 2025 BrainsWay Ltd. misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.11. Operator: Good day, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results